Barcode Five Rights System



Use Barcode to prevent medication errors



ADERS ® is a barcode point of care, (BPOC), solution

Request Info











Practical Compliance Solutions, Corp. helps care facilities reduce risk at the patient's bedside. Our five rights barcode solution is the easiest to implement. Our barcode point of care system can help prevent medication errors in hospitals, long term care facilities, and assisted living communities.

ADERS ® is our barcode solution for the healthcare industry. It helps eliminate medication errors by allowing caregivers to scan NDC barcodes at the patient's bedside, verifying right patient, right drug, right time, right dose, and right route of administration. For more information click the products menu or send us a web request from our Contact menu. Ask for a DEMO CD. It is the full product that is licensed for an evaluation period.

We are offering a 30 day no-obligation free trial of the ADERS ® software. Care facilities can easily determine if ADERS ® is right for them by using the software as a pilot for a single unit or ward. Click here to download a Microsoft Project plan showing how you can implement a five rights point of care barcode pilot in less than a week. If you Don't own MS Project 2003, then here is a PDF copy just to see.... Download Adobe PDF Data Sheet

View a PowerPoint Presentation of ADERS ®.





Current Patient Safety and Drug Safety Updates from the FDA


FDA Press Releases RSS Feed

FDA Roundup: September 23, 2022
Fri, 23 Sep 2022 15:42:39 EDT

  The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

New FDA Draft Guidance Aims to Protect Children who Participate in Clinical Trials
Fri, 23 Sep 2022 10:09:07 EDT

  The FDA issued draft guidance that, when finalized, will provide the agency’s perspective on the ethical considerations for including and protecting children in clinical trials and will assist industry, sponsors and IRBs when considering the enrollment of children.

FDA Roundup: September 20, 2022
Tue, 20 Sep 2022 16:11:13 EDT

  The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

FDA Committed to Strengthening U.S. Infant Formula Supply; Review Provides Roadmap to Support Ongoing Efforts
Tue, 20 Sep 2022 13:48:53 EDT

  Today, the FDA released a review of review activities and decision-making related to the shutdown of Abbott’s Sturgis, Michigan, infant formula facility.

FDA Concludes Internal Review of Agency Actions Related to the U.S. Infant Formula Supply
Tue, 20 Sep 2022 13:48:27 EDT

  Today, the FDA released a review of review activities and decision-making related to the shutdown of Abbott’s Sturgis, Michigan, infant formula facility.

FDA Roundup: September 16, 2022
Fri, 16 Sep 2022 15:36:32 EDT

  The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

FDA and NIH Launch Public-Private Partnership for Rare Neurodegenerative Diseases
Wed, 14 Sep 2022 09:44:07 EDT

  FDA and NIH launch Critical Path for Rare Neurodegenerative Diseases – a public-private partnership aimed at advancing the understanding of rare neurodegenerative diseases and fostering the development of treatments.

FDA Roundup: September 13, 2022
Tue, 13 Sep 2022 14:33:41 EDT

  The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

FDA Roundup: September 9, 2022
Fri, 09 Sep 2022 14:33:58 EDT

  The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

FDA Issues Safety Alert for Squamous Cell Carcinoma and Various Lymphomas in Scar Tissue around Breast Implants
Thu, 08 Sep 2022 14:00:34 EDT

  Today, the FDA issued a safety communication about reports of SCC and various lymphomas in the capsule or scar tissue around breast implants.

Monkeypox Update: FDA Takes Significant Action to Help Expand Access to Testing
Wed, 07 Sep 2022 16:39:44 EDT

  The FDA issued an EUA, guidance and associated templates today to help expand testing capacity in response to the monkeypox public health emergency (PHE).

Certain Philips Respironics Masks for BiPAP, CPAP Machines Recalled Due to Safety Issue with Magnets That May Affect Certain Medical Devices
Tue, 06 Sep 2022 17:14:29 EDT

  Today, the U.S. Food and Drug Administration alerted patients, caregivers and health care providers of recalled Philips Respironics masks for BiPAP, CPAP machines.

FDA Roundup: September 6, 2022
Tue, 06 Sep 2022 15:45:13 EDT

  The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

FDA Roundup: September 2, 2022
Fri, 02 Sep 2022 13:45:52 EDT

  The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

FDA Approves First Treatment for Acid Sphingomyelinase Deficiency, a Rare Genetic Disease
Wed, 31 Aug 2022 13:23:19 EDT

  The FDA approved Xenpozyme (Olipudase alfa) for intravenous infusion in pediatric and adult patients with Acid Sphingomyelinase Deficiency (ASMD), a rare genetic disease that causes premature death.

Coronavirus (COVID-19) Update: FDA Authorizes Moderna, Pfizer-BioNTech Bivalent COVID-19 Vaccines for Use as a Booster Dose
Wed, 31 Aug 2022 09:42:22 EDT

  The FDA amended the emergency use authorizations (EUAs) of the Moderna COVID-19 Vaccine and the Pfizer-BioNTech COVID-19 Vaccine to authorize bivalent formulations of the vaccines for use as a single booster dose at least two months following primary or booster vaccination.

FDA Roundup: August 30, 2022
Tue, 30 Aug 2022 15:08:48 EDT

  The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

FDA Roundup: August 26, 2022
Fri, 26 Aug 2022 15:37:23 EDT

  The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

FDA Removes N95 Respirators from Medical Device Shortage List, Signaling Sufficient Supply
Fri, 26 Aug 2022 11:28:16 EDT

  Today, the FDA announced the removal of N95 respirators from the agency’s medical device shortage list.

FDA and Mexican Counterparts Report Progress in Food Safety at Second Annual Partnership Meeting
Thu, 25 Aug 2022 16:42:16 EDT

  Today, the U.S. Food and Drug Administration and its regulatory counterparts in Mexico COFEPRIS and SENASICA held the second annual Food Safety Partnership Meeting.

Food and Drugs Administration--Recalls/Safety Alerts

TreeHouse Foods Announces Voluntary Recall of Certain Tuscan Garden Restaurant Style Italian Dressing Due to Undeclared Wheat and Soy
Sat, 24 Sep 2022 00:00:00 EDT

  OAK BROOK, Ill. (September 23, 2022) – TreeHouse Foods, Inc. (NYSE: THS) is voluntarily recalling one lot of Restaurant Style Italian Dressing sold under the brand name Tuscan Garden. This recall is being conducted because the product is labeled as Restaurant Style Italian Dressing, while some of th

Van Law Food Products Issues Allergy Alert on Undeclared Soy and Wheat in Product Expanded
Fri, 23 Sep 2022 00:00:00 EDT

  VanLaw Food Products Inc. is expanding its recall of Whole Foods Market 365 Organic Creamy Caesar Dressing because it contains undeclared Soy and Wheat allergens. The recall is being expanded to include Whole Foods Market 365 Organic Creamy Caesar Dressing with a BEST IF USED BY DATE of SEP 21 22 th

Arcade Snacks Issues Allergy Alert on Undeclared Egg in Candy Corn
Fri, 23 Sep 2022 00:00:00 EDT

  Arcade Snacks of Auburn, MA is recalling its 15 ounce packages of Candy Corn because they may contain undeclared egg. People who have allergies to egg run the risk of serious or life-threatening allergic reaction if they consume these products.

World Variety Produce, Inc. Voluntarily Recalls Select Lots of Melissa’s Dutch Red Potatoes with Dijon Mustard Sauce Because it Contains Undeclared Egg Allergens
Wed, 21 Sep 2022 14:10:00 EDT

  People with an allergy or severe sensitivity to Egg run the risk of serious or life-threatening allergic reaction if they consume this ingredient. The product was sold in the produce department and distributed in the states of Arizona, California, Florida, Iowa, Idaho, Kansas, Louisiana, Mississippi

GHGA Recalls Various Ready-To-Eat Vegetable Products Due to Possible Listeria Monocytogenes Contamination
Tue, 20 Sep 2022 00:00:00 EDT

  GHGA is recalling various products (see chart below) due to the potential to be contaminated with Listeria monocytogenes. No other GHGA products are affected by this recall. Listeria monocytogenes is an organism which can cause serious and sometimes fatal infections in young children, frail or elder

Salon Technologies, Inc. Issues Voluntary Nationwide Recall of Antica Ocean Citron Hand Sanitizer ( Alcohol ) Gel 65% Due to the Presence of Benzene
Sat, 17 Sep 2022 00:00:00 EDT

  Orlando, Florida. Salon Technologies International. Inc. is voluntarily recalling one lot of Antica Ocean Citron Hand Sanitizer (alcohol) Gel 65%, Lot 1166A. Expiration 6/18/2023 to the consumer level. Firm lab testing has found the product to contain benzene. Benzene is classified as a human carci


Voluntary Recall of Certain Colgate Products Sold at Family Dollar Stores Because They Were Stored Outside of Temperature Requirements
Thu, 15 Sep 2022 11:03:00 EDT

  Family Dollar is initiating a voluntary retail level product recall of certain products regulated by the U.S. Food and Drug Administration (FDA) that were stored and shipped to a limited number of stores in AZ, CA, GA, ID, IN, MT, NM, NV, OR, TX, and UT on or around May 1, 2022 through June 21, 202

Muktanand Foods Inc. Issues an Allergy Alert on Ankur Brand Golden Raisin 14 Oz (400 GM)
Thu, 08 Sep 2022 00:00:00 EDT

  “ANKUR” Muktanand Foods Inc. 483 Thomas Dr. Bensenville, IL 60106 is recalling its 14 Oz (400 gm) packages of “Golden Raisin” because they may contain undeclared sulfites. People who have severe sensitivity to Sulfites may run the risk of serious or life-threatening reactions, if they consume this p

Philips Respironics Alerts Customers Worldwide of Updated Instructions and Labeling of Specific Sleep Therapy Masks That Contain Magnetic Headgear Clips Due to Potential Risk of Serious Injury
Tue, 06 Sep 2022 00:00:00 EDT

  Pittsburgh, Pennsylvania – Royal Philips’ (NYSE: PHG; AEX: PHIA) subsidiary Philips Respironics is alerting users of certain CPAP or Bi-Level PAP therapy masks with magnetic headgear clips or straps that these devices should not be used by or near patients and their household members, caregivers and

St. James Smokehouse Voluntary Recalls Scotch Reserve Scottish Smoked Salmon 4oz (Lot# 123172) Because Of Possible Health Risk
Fri, 02 Sep 2022 12:42:00 EDT

  St James Smokehouse of Miami, Florida is voluntary recalling 93 cases of St. James Smokehouse brand, Scotch Reserve Scottish Smoked Salmon, 4oz Packages (Product of Scotland) because it has the potential to be contaminated with Listeria monocytogenes, an organism which can cause serious and sometime

Albertsons Companies Expands Voluntary Recall of Select ReadyMeals Seafood Products Due to Undeclared Allergens
Wed, 31 Aug 2022 00:00:00 EDT

  Albertsons Companies today announced it is expanding its July 19, 2022, voluntary recall of ReadyMeals seafood items due to allergens not listed on the ingredient labels. The recall, which is being conducted in continued collaboration with the U.S. Food and Drug Administration, was initiated after a

Tai Phat Wholesalers, LLC Recalls “Three Coins Dried Mushrooms” Because of Possible Health Risk
Mon, 29 Aug 2022 00:00:00 EDT

  Tai Phat Wholesalers, LLC of Capitol Heights, MD is recalling 4 types of packages of its “Three Coins Dried Mushrooms” because they have the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, an

Keswick Creamery at Carrock Farm, LLC Recalls Cheese Because of Possible Health Risk
Mon, 29 Aug 2022 00:00:00 EDT

  Keswick Creamery of Newburg, Pa is recalling Calverley Cheese, Vulkwin’s Folly Cheese, Vermeer Cheese, Havarti Cheese, Wallaby Cheese, Cider Washed Tomme Cheese, Feta Cheese, Whole Milk Ricotta, Bovre Cheese (plain, oregano and garlic, herbes de provence, cranberry and honey) and Quark Cheese (plain

Food Co. Issues Allergy Alert on Undeclared Coconut in Product
Fri, 26 Aug 2022 00:00:00 EDT

  Toufayan Bakery is voluntarily recalling Publix GreenWise Animal Crackers with a UPC of 0-41415-12009-9. (Located on the back of the pouch) and with an expiration date of Feb 05, 2023 due to an undeclared tree nut allergen. The cookies are packaged in pouches, net weight 8 oz and may contain coconut

Van Law Food Products Issues Allergy Alert on Undeclared Soy and Wheat in Product
Fri, 26 Aug 2022 00:00:00 EDT

  Van Law Food Products Inc. is recalling Whole Foods Market 365 Organic Creamy Caesar Dressing because it contains undeclared Soy and Wheat allergens.
People with an allergy or severe sensitivity to Soy or Wheat run the risk of serious or life-threatening allergic reaction if they consume these


Piantedosi Baking Company, Inc. Issues Voluntary Recall Due to the Recall of a Raw Material from Lyons Magnus
Thu, 25 Aug 2022 20:38:00 EDT

  Out of an abundance of caution, Piantedosi Baking Company, Inc. is voluntarily recalling select dinner rolls, sandwich rolls and bun products listed below that were used in limited products made between March 21,2022 and April 25, 2022, following the expanded Lyons Magnus recall dated August 10, 202

D.F. Stauffer Biscuit Co., Inc. Issues a Voluntary Recall on Market Pantry White Fudge Animal Cookies with a Best By Date of 21FEB2023 Due to Possible Foreign Object Contamination
Wed, 24 Aug 2022 00:00:00 EDT

  D. F. Stauffer Biscuit Co., Inc. is voluntarily recalling 44 oz Market Pantry White Fudge Animal Cookies because they may contain metal. The product comes in a clear plastic jug formed to a bear shape. The recall affects only the following Best By Date, Lot Numbers, and time stamps, printed on the

Rushdi Foods Issues a Voluntary Recall on One Lot of their Mighty Sesame Organic Tahini 10.9 oz Squeeze Bottle
Tue, 23 Aug 2022 00:00:00 EDT

  Rushdi Food Industries, an Israeli based manufacturer, is voluntarily recalling their Mighty Sesame 10.9 Oz Organic Tahini (Squeezable) with the specific expiration date of 3/28/23 due t0 potential Salmonella contamination. Salmonella is an organism which can cause serious and sometimes fatal infect

South Georgia Pecan Co. Recalls Great Value 4oz. Walnut Chopped Pouches Due to Pouch Containing Pecan Pieces
Tue, 23 Aug 2022 00:00:00 EDT

  South Georgia Pecan Co. is recalling Great Value Walnut Chopped 4oz. Pouches Lot #29329 Best If Used By April 29, 2023 due to pouches containing pecan pieces instead of walnuts. This recall has been initiated due to mislabeling issue where a packaging run of pecans was labeled as Chopped Walnuts. Pe

Hospira Issues A Voluntary Nationwide Recall For One Lot of Propofol Injectable Emulsion (Containing Benzyl Alcohol), Due To The Potential Presence of Visible Particulates
Mon, 22 Aug 2022 18:44:00 EDT

  Hospira, Inc., a Pfizer company, is voluntarily recalling one lot of Propofol Injectable Emulsion (containing benzyl alcohol), 100mL Single Patient Use Glass Fliptop Vial; lot EA7470, to the user level due to visible particulates observed in two vials during annual examination of retention samples.

What's New: Drugs RSS Feed

What's New Related to Drugs
Fri, 23 Sep 2022 17:54:12 EDT

  Want to know what's new on drugs from FDA? This page provides quick links to the latest on a variety of topics including: drug approvals, safety warnings, drug shortages, etc.

CDER Small Business & Industry Assistance (SBIA)
Fri, 23 Sep 2022 14:40:59 EDT

  A Comprehensive Resource for Information on Human Drug Development in Regulation

Advancing Generic Drug Development: Translating Science to Approval - 09/20/2022
Fri, 23 Sep 2022 14:40:23 EDT

  SBIA Conference Advancing Generic Drug Development: Translating Science to Approval

Frequently requested or proactively posted compliance records
Fri, 23 Sep 2022 13:20:48 EDT

  Frequently requested inspection records of foreign pharmaceutical manufacturing facilities

Over-The-Counter Monograph Drug User Fee Program (OMUFA)
Fri, 23 Sep 2022 12:39:59 EDT

  A user fee program for nonprescription (over-the-counter or OTC) monograph drugs would be a potential funding mechanism to supplement congressional non user-fee appropriations.

Office of Infectious Diseases Research Activities
Fri, 23 Sep 2022 10:58:12 EDT

  Overview of research needs, requests for information (RFIs), public workshops/meetings, opportunities for collaboration (this applies to RFI), notable guidances related to regulatory science, externally awarded research studies, and other important regulatory science and research activities.

Guidance Snapshot Pilot
Fri, 23 Sep 2022 10:34:00 EDT

  Guidance Snapshots are a communication tool that provide highlights from the document using visuals and plain language. This pilot program is intended to increase awareness for FDA guidance documents to support the efficient application of the documents’ recommendations.

FDA updates on hand sanitizers consumers should not use
Fri, 23 Sep 2022 10:07:44 EDT

  FDA Warns consumers and healthcare professionals of Hand Sanitizers contaminated with Methanol

Ethical Considerations for Clinical Investigations of Medical Products Involving Children
Fri, 23 Sep 2022 09:32:55 EDT

  Clinical / Medical

FDA Issues New Guidance to Help Facilitate Availability of Naloxone to Prevent Opioid Overdoses and Reduce Death
Fri, 23 Sep 2022 08:47:28 EDT

  The FDA is building on our actions by helping facilitate the availability and access to this life saving medication.

Guidance Recap Podcast | Ethical Considerations for Clinical Investigations of Medical Products Involving Children
Fri, 23 Sep 2022 00:01:04 EDT

  Thoughts on newly published draft guidance titled, “Ethical Considerations for Clinical Investigations of Medical Products Involving Children.”

Guidance Recap Podcast | Selecting, Developing or Modifying Fit-for-Purpose Clinical Outcomes Assessments
Thu, 22 Sep 2022 17:01:42 EDT

  Guidance Recap Podcast: Selecting, Developing or Modifying Fit-for-Purpose Clinical Outcomes Assessments

Data Standards Catalog v8.2
Thu, 22 Sep 2022 16:15:10 EDT

  Data Standards Catalog v8.2

Novel Drug Approvals for 2022
Thu, 22 Sep 2022 15:31:34 EDT

  Innovative drugs often mean new treatment options for patients and advances in health care for the American public.

Compounding: Inspections, Recalls, and other Actions
Thu, 22 Sep 2022 15:28:53 EDT

  Human drug compounding; FDA inspections; compounding recalls

CDERLearn Training and Education
Thu, 22 Sep 2022 14:03:19 EDT

  Continuing Education and Training opportunities for healthcare professionals, academia, students and consumers.

Drug Supply Chain Security Act Law and Policies
Thu, 22 Sep 2022 13:59:16 EDT

  Since the Drug Supply Chain Security Act (DSCSA) was enacted in 2013, FDA has issued the following guidance and policy documents

Psychopharmacologic Drugs Advisory Committee Roster
Thu, 22 Sep 2022 13:41:27 EDT

  Psychopharmacologic Drugs Advisory Committee Roster

REMS Compliance Program
Thu, 22 Sep 2022 13:18:53 EDT

  REMS Compliance Program

Information about Naloxone
Thu, 22 Sep 2022 11:30:29 EDT

  Naloxone is a medication that rapidly reverses the effects of opioid overdose and is the standard treatment for overdose. In the wake of the opioid epidemic, efforts are underway to make this emergency treatment more readily available and more accessible.

Whats New Vaccines Blood Biologics RSS Feed

What’s New for Biologics
Fri, 23 Sep 2022 15:03:05 EDT

  Latest news from the Center for Biologics Evaluation and Research

Devices Guidances
Fri, 23 Sep 2022 14:59:24 EDT

  This page lists Medical Device Guidance documents.

Ethical Considerations for Clinical Investigations of Medical Products Involving Children
Fri, 23 Sep 2022 09:32:55 EDT

  Clinical / Medical

Essential Regulatory Laboratory Activities
Thu, 22 Sep 2022 16:06:14 EDT

  CBER is an Essential Regulatory Laboratory (ERL) in WHO’s Global Influenza Surveillance and Response System (GISRS) in collaboration with the United Kingdom, Australia, and Japan regulatory authorities.

Gardasil Vaccine Safety
Thu, 22 Sep 2022 15:53:39 EDT

  Gardasil vaccine safety monitoring activities and findings as reported by FDA and CDC.

WHO Vaccine Prequalification Program
Thu, 22 Sep 2022 15:51:07 EDT

  The WHO, through the Quality Safety and Standards (QSS) Unit of the Department of Immunization, Vaccines and Biologicals (IVB), provides advice to the United Nations Children’s Fund (UNICEF) and other United Nations (UN) agencies on the acceptability, in principle, of vaccines considered for purchase by such agencies for vaccination programs they administer. The WHO does so through its vaccine prequalification program.

OTAT Learn
Thu, 22 Sep 2022 15:18:16 EDT

  Welcome to OTAT Learn (Office of Tissues and Advanced Therapies; previously OCTGT Learn), the Center for Biologics, Evaluation and Research's (CBER) web page for industry education.

COVID-19 Bivalent Vaccine Boosters
Thu, 22 Sep 2022 14:20:58 EDT

  A single booster dose with an updated bivalent COVID-19 vaccine provides broad protection against COVID-19 and is expected to provide better protection against COVID-19 caused by the currently circulating Omicron variant.

Evaluation of the Quality of Viral Vaccines Based on Molecular Consistency
Thu, 22 Sep 2022 12:49:58 EDT

  A description of Konstantin Chumakov's research program and related publications.

Guidances, Federal Register Notices & Standard Operating Policy & Procedure for Advertising & Promotional Labeling
Thu, 22 Sep 2022 12:15:39 EDT

  Guidances, Federal Register Notices & Standard Operating Policy & Procedure for Advertising & Promotional Labeling

Bovine Spongiform Encephalopathy (BSE) Questions and Answers
Thu, 22 Sep 2022 11:31:54 EDT

  Bovine Spongiform Encephalopathy (BSE) Questions and Answers

Vaccines and Related Biological Products Advisory Committee September 22, 2022 Meeting Announcement - 09/22/2022
Thu, 22 Sep 2022 11:23:33 EDT

  This is the main page for the CBER Vaccines and Related Biological Products Advisory Committee September 22, 2022 Meeting Announcement.

Thimerosal and Vaccines
Thu, 22 Sep 2022 10:37:08 EDT

  Thimerosal is a compound that has been widely used as a preservative in a number of biological and drug products. All vaccines routinely recommended for children 6 years of age and younger in the U.S. are available in formulations that do not contain thimerosal. The use of thimerosal as a preservative in vaccines has declined due to reformulation and development of new vaccines in single-use presentations.

Study Data Technical Conformance Guide - Technical Specifications Document
Wed, 21 Sep 2022 17:23:44 EDT

  This technical specifications document represents the Food and Drug Administration's (FDA's) current thinking on this topic.

Pfizer-BioNTech COVID-19 Vaccines
Wed, 21 Sep 2022 17:10:12 EDT

  Information about the Comirnaty, Pfizer-BioNTech COVID-19 Vaccine, and Pfizer-BioNTech COVID-19 Vaccine, Bivalent. Updated COVID-19 vaccine boosters are now FDA-authorized.

Moderna COVID-19 Vaccines
Wed, 21 Sep 2022 17:09:41 EDT

  Information about Spikevax, Moderna COVID-19 Vaccine and Moderna COVID-19 Vaccine, Bivalent. Updated COVID-19 vaccine boosters are now FDA-authorized.

Modified Factor Xa Polypeptides to Recover Clotting Activity in Subjects Treated with Direct Oral Anticoagulants (DOACs)
Wed, 21 Sep 2022 15:18:31 EDT

  Modified Factor Xa Polypeptides to Recover Clotting Activity in Subjects Treated with Direct Oral Anticoagulants (DOACs)

Workshops, Meetings & Conferences (Biologics)
Wed, 21 Sep 2022 14:38:04 EDT

  Information on CBER sponsored or co-sponsored meetings, conferences and workshops about various biologics in order to educate the public and seek the opinion of interested parties.

Rare Diseases at FDA
Wed, 21 Sep 2022 09:19:35 EDT

  The FDA works with many people and groups, such as patients, caregivers, and drug and device manufactures, to support rare disease product development.

Advisory Committees Give FDA Critical Advice and the Public a Voice
Wed, 21 Sep 2022 09:09:50 EDT

  Not familiar with FDA’s advisory committees? These committees provide independent, expert advice to the FDA on a range of complex scientific, technical and policy issues related to the development and evaluation of FDA-regulated products.





See how to prevent medication errors with bar codes using ADERS. Get your free pilot started today.





 
 

Contact Us


Corporate Headquarters


Practical Compliance Solutions
One Orient Way
Suite F156
Rutherford, NJ 07070
  201-728-8809


40.827731 N 74.101029 W

Connect With Us

   
 
 
© 2002 - 2022 - Copyright Practical Compliance Solutions - All rights reserved